International Business Machines Corp. is navigating the aftermath of a historic single-day stock decline, even as the company signals its core operations remain robust. As the share price attempts to recover from one of its worst trading sessions in a quarter-century, IBM is concurrently announcing major contract wins, publishing significant research, and bolstering its leadership. The central debate for investors is whether the recent panic was an overreaction or if the market is underestimating deeper structural challenges.
A Stunning Market Reaction
The catalyst for the recent volatility was an announcement on February 23rd from AI firm Anthropic regarding its Claude-Code tool’s capability to modernize COBOL. This programming language, originating in the late 1950s, still runs predominantly on IBM systems and is widely used in payment processing and retail systems. Investor concern that AI tools could encroach upon this lucrative modernization business triggered a sell-off, sending IBM shares down over 13% that day—the most severe daily loss in more than 25 years.
Since hitting a 52-week high of $324.90 in November, the equity has declined by nearly 40%. Year-to-date, the stock is down approximately 22%, a stark contrast to the positive performance of the S&P 500 index. Following the dramatic sell-off, the price has shown signs of stabilization, with several market analysts contending that IBM’s position is not so easily dismantled by AI competition.
Financial Resilience and Shareholder Returns
Operationally, IBM’s financial metrics demonstrate stability. The company generated $7.6 billion in free cash flow during the fourth quarter of 2025, representing a $1.4 billion year-over-year increase. In that final quarter alone, $1.6 billion was returned to shareholders via dividends. IBM has raised its dividend payout for 30 consecutive years and has made uninterrupted payments since 1916, solidifying its status as a Dividend Aristocrat. The next quarterly dividend of $1.68 per share is scheduled for March 10.
Revenue for Q4 2025 reached $19.23 billion, a 9.6% increase from the prior year and notably above the industry average. On the artificial intelligence front, IBM’s watsonx platform is gaining traction, with bookings for generative AI surpassing $12 billion.
Securing Major Government Contracts
Amid the market turbulence, IBM secured a significant defense contract. The U.S. Department of Defense awarded the company a deal worth up to $112 million over five years. The project involves modernizing pricing systems in military commissaries worldwide, encompassing 177 U.S. locations and 58 international branches across twelve countries.
The scope includes hardware maintenance, software licenses, security updates, and training for existing electronic shelf label systems. This award represents another component in IBM’s expanding federal government business. Separately, the company was selected for the Missile Defense Agency’s SHIELD program—a framework agreement with a potential ceiling of $151 billion.
Should investors sell immediately? Or is it worth buying IBM?
Cybersecurity Landscape: AI as a Double-Edged Sword
IBM’s recently released X-Force Threat Intelligence Index for 2026 illustrates how cybercriminals are exploiting vulnerabilities at an accelerating pace, a trend fueled by AI-powered attack tools. Key findings from the report include:
- Attacks targeting publicly accessible applications surged by 44%, often due to missing authentication mechanisms.
- Active ransomware and extortion groups increased by 49%, with publicly identified victims rising by approximately 12%.
- Vulnerability exploitation was the most common attack method in 2025, accounting for 40% of incidents.
- Large-scale software supply chain compromises have nearly quadrupled since 2020.
This research underscores IBM’s role as a security solutions provider for major enterprises—a segment considered less vulnerable to pressures affecting the consulting division.
The Consulting Conundrum: Overblown Fear or Real Threat?
Even before the Anthropic-related shock, IBM’s consulting unit was growing at a modest pace of just 3%. Should clients increasingly turn to AI tools for code modernization instead of IBM’s consultants, it could significantly impact a segment generating roughly $5 billion in revenue per quarter.
Analysts at Evercore ISI challenged the market’s panic, maintaining their “Outperform” rating and a $345 price target. They argue that IBM offers its own modernization tools, such as the watsonx Code Assistant for Z, and that the current mainframe cycle (z17) is performing better than its predecessor (z16). These experts posit that the company’s genuine growth engines are its AI and hybrid cloud divisions, not consulting. They believe the market is conflating a threat to one business segment with an existential risk to the entire corporation.
Forward Guidance and Valuation
For the full 2026 fiscal year, IBM projects revenue growth exceeding 5% at constant currency rates. Based on current exchange rates, currency effects are expected to contribute approximately an additional half a percentage point. The company also anticipates free cash flow will increase by around $1 billion.
The stock currently trades at a price-to-earnings ratio of approximately 21, with annual free cash flow of $14 billion and a dividend yield of 3%. The coming two quarters will reveal whether fears about the consulting business materialize in revenue figures or if analysts calling the sell-off an overreaction are proven correct.
Ad
IBM Stock: Buy or Sell?! New IBM Analysis from March 3 delivers the answer:
The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 3.
IBM: Buy or sell? Read more here...
